C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
167/211, 260/254
C07D 401/06 (2006.01) A61K 31/505 (2006.01) A61K 31/535 (2006.01) C07D 401/14 (2006.01) C07D 413/14 (2006.01)
Patent
CA 2033363
AsSTRACT Compounds of the formula: Image in which R1 and R2 are each hydrogen, halogen, nitro, amino, protected amino, hydroxyamino, lower alkyl, hydroxy, protected hydroxy, sulfamoyl, carboxy, protected carboxy, mercapto, heterocyclic-carbonyl, heterocyclic-(lower)alkyl, lower alkylthio, hydroxy(lower)alkyl or protected hydroxy(lower)alkyl, R3 is aryl which may have suitable substituent(s), and A is lower alkylene, or pharmaceutically acceptable salts thereof. These compounds can be used as dopamine receptor agonist, 5-HT receptor antagonist, especially 5-HT2 receptor antagonist; .alpha.1 receptor antagonists. The therapeutic treatment of these receptor mediated diseases, particu- larly hypertension, cardiovascular disorder (e.g. angina pectoris, myocardial infarction), Parkinsonism, and the like is also disclosed. The preparation of these compounds, and pharmaceutical compositions containing them are also described.
Hashimoto Masashi
Itoh Yoshikuni
Shimazaki Norihiko
Tanaka Hirokazu
Yamazaki Hitoshi
Fujisawa Pharmaceutical Co. Ltd.
Hashimoto Masashi
Itoh Yoshikuni
Shimazaki Norihiko
Swabey Ogilvy Renault
LandOfFree
Quinazoline derivatives and their preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinazoline derivatives and their preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazoline derivatives and their preparation will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1763627